Combination treatment with anti-HER2 therapeutic antibody RC48, PD-1 inhibitor, radiotherapy, and granulocyte macrophage-colony stimulating factor (GM-CSF) in patient with metastatic gastric cancer: a case report

被引:1
作者
Liu, Zhuixing [1 ]
Wang, Fang [2 ]
Zhang, Yingqi [2 ]
Lu, Jun [2 ]
Yang, Yang [2 ]
机构
[1] Xian Int Med Ctr Hosp, Dept Oncol, Xian, Peoples R China
[2] Xi'an Int Med Ctr Hosp, Dept Radiotherapy & Oncol, Xian, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2024年 / 15卷
关键词
RC48; PD-1; inhibitor; stereotactic body radiotherapy; GM-CSF; gastric cancer; HER2-positive; GASTROESOPHAGEAL JUNCTION; PLUS CHEMOTHERAPY; 2ND-LINE THERAPY; SOLID TUMORS; OPEN-LABEL; ADENOCARCINOMA; IMMUNOTHERAPY; ESOPHAGEAL; SAFETY; CAMRELIZUMAB;
D O I
10.3389/fimmu.2024.1321946
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
HER2 overexpression/amplification is a prevalent driver in various types of cancer, including gastric cancer (GC). Limited options are available for patients with HER2-positive metastatic gastric cancer, particularly those who do not respond to the standard therapy of HER2 antibody trastuzumab combined with chemotherapy. Previous research suggests that combining a PD-1 inhibitor with radiotherapy and granulocyte macrophage-colony stimulating factor (PRaG regimen) may enhance the antitumor effects in patients with chemotherapy-resistant metastatic solid tumors. In this case study, we presented a potential treatment strategy of a patient having HER2-positive and PD-L1-negative gastric adenocarcinoma. The patient showed rapid tumor progression even after surgery and multiple trastuzumab plus chemotherapy treatments. To address this, we employed a novel anti-HER2 antibody called RC48 in combination with PRaG regimen therapy (PRaG3.0). The patient demonstrated a positive response after two treatment cycles and achieved a progression-free survival time of 6.5 months. This case highlights the potential of four-combination therapies for treating refractory, multiorgan, HER2-positive, PD-L1-negative metastatic gastric cancer. Additionally, varying radiation doses in targeting dual foci is critical to enhance tumor immunotherapy.
引用
收藏
页数:10
相关论文
共 53 条
[41]   Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer [J].
Seo, Incheol ;
Lee, Hye Won ;
Byun, Sang Jun ;
Park, Jee Young ;
Min, Hyeonji ;
Lee, Sung Hwan ;
Lee, Ju-Seog ;
Kim, Shin ;
Bae, Sung Uk .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2021, 9 (03)
[42]   Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial [J].
Shitara, Kohei ;
Van Cutsem, Eric ;
Bang, Yung-Jue ;
Fuchs, Charles ;
Wyrwicz, Lucjan ;
Lee, Keun-Wook ;
Kudaba, Iveta ;
Garrido, Marcelo ;
Chung, Hyun Cheol ;
Lee, Jeeyun ;
Castro, Hugo Raul ;
Mansoor, Wasat ;
Braghiroli, Maria Ignez ;
Karaseva, Nina ;
Caglevic, Christian ;
Villanueva, Luis ;
Goekkurt, Eray ;
Satake, Hironaga ;
Enzinger, Peter ;
Alsina, Maria ;
Benson, Al ;
Chao, Joseph ;
Ko, Andrew H. ;
Wainberg, Zev A. ;
Kher, Uma ;
Shah, Sukrut ;
Kang, S. Peter ;
Tabernero, Josep .
JAMA ONCOLOGY, 2020, 6 (10) :1571-1580
[43]   Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer [J].
Shitara, Kohei ;
Bang, Yung-Jue ;
Iwasa, Satoru ;
Sugimoto, Naotoshi ;
Ryu, Min-Hee ;
Sakai, Daisuke ;
Chung, Hyun-Cheol ;
Kawakami, Hisato ;
Yabusaki, Hiroshi ;
Lee, Jeeyun ;
Saito, Kaku ;
Kawaguchi, Yoshinori ;
Kamio, Takahiro ;
Kojima, Akihito ;
Sugihara, Masahiro ;
Yamaguchi, Kensei .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (25) :2419-2430
[44]   Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Sung, Hyuna ;
Ferlay, Jacques ;
Siegel, Rebecca L. ;
Laversanne, Mathieu ;
Soerjomataram, Isabelle ;
Jemal, Ahmedin ;
Bray, Freddie .
CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (03) :209-249
[45]   Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials [J].
Theelen, Willemijn S. M. E. ;
Chen, Dawei ;
Verma, Vivek ;
Hobbs, Brian P. ;
Peulen, Heike M. U. ;
Aerts, Joachim G. J., V ;
Bahce, Idris ;
Niemeijer, Anna Larissa N. ;
Chang, Joe Y. ;
de Groot, Patricia M. ;
Nguyen, Quynh-Nhu ;
Comeaux, Nathan, I ;
Simon, George R. ;
Skoulidis, Ferdinandos ;
Lin, Steven H. ;
He, Kewen ;
Patel, Roshal ;
Heymach, John ;
Baas, Paul ;
Welsh, James W. .
LANCET RESPIRATORY MEDICINE, 2020, 9 (05) :467-475
[46]   Effect of Pembrolizumab After Stereotactic Body Radiotherapy vs Pembrolizumab Alone on Tumor Response in Patients With Advanced Non-Small Cell Lung Cancer: Results of the PEMBRO-RT Phase 2 Randomized Clinical Trial [J].
Theelen, Willemijn S. M. E. ;
Peulen, Heike M. U. ;
Lalezari, Ferry ;
van der Noort, Vincent ;
de Vries, Jeltje F. ;
Aerts, Joachim G. J. V. ;
Dumoulin, Daphne W. ;
Bahce, Idris ;
Niemeijer, Anna-Larissa N. ;
de Langen, Adrianus J. ;
Monkhorst, Kim ;
Baas, Paul .
JAMA ONCOLOGY, 2019, 5 (09) :1276-1282
[47]  
Thorsson V, 2019, IMMUNITY, V51, P411, DOI [10.1016/j.immuni.2019.08.004, 10.1016/j.immuni.2018.03.023]
[48]   HER2 screening data from ToGA: targeting HER2 in gastric and gastroesophageal junction cancer [J].
Van Cutsem, Eric ;
Bang, Yung-Jue ;
Feng-Yi, Feng ;
Xu, Jian M. ;
Lee, Keun-Wook ;
Jiao, Shun-Chang ;
Chong, Jorge Leon ;
Lopez-Sanchez, Roberto I. ;
Price, Timothy ;
Gladkov, Oleg ;
Stoss, Oliver ;
Hill, Julie ;
Ng, Vivian ;
Lehle, Michaela ;
Thomas, Marlene ;
Kiermaier, Astrid ;
Rueschoff, Josef .
GASTRIC CANCER, 2015, 18 (03) :476-484
[49]   PD-L1 checkpoint blockade promotes regulatory T cell activity that underlies therapy resistance [J].
van Gulijk, Mandy ;
van Krimpen, Anneloes ;
Schetters, Sjoerd ;
Eterman, Mike ;
van Elsas, Marit ;
Mankor, Joanne ;
Klaase, Larissa ;
de Bruijn, Marjolein ;
van Nimwegen, Menno ;
van Tienhoven, Tim ;
van Ijcken, Wilfred ;
Boon, Louis ;
van der Schoot, Johan ;
Verdoes, Martijn ;
Scheeren, Ferenc ;
van der Burg, Sjoerd H. ;
Lambrecht, Bart N. ;
Stadhouders, Ralph ;
Dammeijer, Floris ;
Aerts, Joachim ;
van Hall, Thorbald .
SCIENCE IMMUNOLOGY, 2023, 8 (83)
[50]   In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment [J].
Vanpouille-Box, Claire ;
Pilones, Karsten A. ;
Wennerberg, Erik ;
Formenti, Silvia C. ;
Demaria, Sandra .
VACCINE, 2015, 33 (51) :7415-7422